Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse T Jacob

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Open Forum Infectious Diseases|July 16, 2019
Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated <i>Staphylococcus aureus</i> BacteremiaDavid Phillip Serota, Emily D Niehaus, Marcos C Schechter, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2022
Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistanceLucy S Witt, Danielle Barrios Steed, Eileen M Burd, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 16, 2024
Derivation of a risk-adjusted model to predict antibiotic prescribing among hospitalists in an academic healthcare networkUdodirim N Onwubiko, Christina Mehta, Zanthia Wiley, et al.
Open Forum Infectious Diseases|January 17, 2022
Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort StudyMax W Adelman, Chris W Bower, Julian E Grass, et al.
Open Forum Infectious Diseases|February 17, 2022
Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase-Producing Enterobacterales Urinary Tract InfectionsDaniel T Anderson, Benjamin Albrecht, K Ashley Jones, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 24, 2025
Estimating the likelihood of hospitalists to repeatedly prescribe high rates of antibioticsRadhika Prakash Asrani, Samuel Parks, Chad Robichaux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2019
Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network AnalysisChris W Bower, Daniel W Fridkin, Hannah M Wolford, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2021
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational studyJessica Howard-Anderson, Michelle Davis, Alexander M Page, et al.
Jac-Antimicrobial Resistance|March 22, 2024
Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant EnterobacteralesChristina K Lin, Alex Page, Sarah Lohsen, et al.
Antibiotics (Basel, Switzerland)|November 24, 2020
Absence of <i>mgrB</i> Alleviates Negative Growth Effects of Colistin Resistance in <i>Enterobacter cloacae</i>Jessie E Wozniak, Aroon T Chande, Eileen M Burd, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Open Forum Infectious Diseases|July 16, 2019
Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated <i>Staphylococcus aureus</i> BacteremiaDavid Phillip Serota, Emily D Niehaus, Marcos C Schechter, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2022
Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistanceLucy S Witt, Danielle Barrios Steed, Eileen M Burd, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 16, 2024
Derivation of a risk-adjusted model to predict antibiotic prescribing among hospitalists in an academic healthcare networkUdodirim N Onwubiko, Christina Mehta, Zanthia Wiley, et al.
Open Forum Infectious Diseases|January 17, 2022
Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort StudyMax W Adelman, Chris W Bower, Julian E Grass, et al.
Open Forum Infectious Diseases|February 17, 2022
Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase-Producing Enterobacterales Urinary Tract InfectionsDaniel T Anderson, Benjamin Albrecht, K Ashley Jones, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 24, 2025
Estimating the likelihood of hospitalists to repeatedly prescribe high rates of antibioticsRadhika Prakash Asrani, Samuel Parks, Chad Robichaux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2019
Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network AnalysisChris W Bower, Daniel W Fridkin, Hannah M Wolford, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2021
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational studyJessica Howard-Anderson, Michelle Davis, Alexander M Page, et al.
Jac-Antimicrobial Resistance|March 22, 2024
Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant EnterobacteralesChristina K Lin, Alex Page, Sarah Lohsen, et al.
Antibiotics (Basel, Switzerland)|November 24, 2020
Absence of <i>mgrB</i> Alleviates Negative Growth Effects of Colistin Resistance in <i>Enterobacter cloacae</i>Jessie E Wozniak, Aroon T Chande, Eileen M Burd, et al.
Pageof 15